Charles River Laboratories traded at $226.01 this Wednesday July 6th, increasing $3.29 or 1.48 percent since the previous trading session. Looking back, over the last four weeks, Charles River Laboratories gained 8.58 percent. Over the last 12 months, its price fell by 41.02 percent. Looking ahead, we forecast Charles River Laboratories to be priced at 212.90 by the end of this quarter and at 196.06 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Agilent 121.18 0.62 0.51% -18.94%
AmerisourceBergen 139.84 -0.87 -0.62% 21.56%
Align Technology 249.54 -4.57 -1.80% -59.24%
Elevance Health Inc 484.27 7.33 1.54% 24.97%
Bio-Rad Laboratories 509.67 3.67 0.73% -24.31%
Bruker 64.55 -0.44 -0.68% -18.51%
Cardinal Health 52.64 0.39 0.75% -7.68%
Cigna 271.09 6.25 2.36% 14.90%
Charles River Laboratories 226.01 3.29 1.48% -41.02%
Catalent 109.20 3.21 3.03% -4.70%
CVS Health 93.19 0.66 0.71% 14.57%
Quest Diagnostics 135.94 2.36 1.77% 0.97%
Danaher 260.04 4.53 1.77% -6.65%
Galapagos 56.20 1.30 2.37% -0.90%
Hologic 70.88 0.69 0.98% 1.78%
Humana 477.48 4.56 0.96% 4.37%
Illumina 195.39 2.37 1.23% -58.73%
Incyte Corp 79.72 0.47 0.59% -2.93%
IQVIA Holdings Inc 216.00 0.69 0.32% -14.94%
Laboratory Of America 243.88 3.89 1.62% -13.29%
Lonza Group 548.20 18.60 3.51% -19.29%
McKesson 321.54 -0.84 -0.26% 69.37%
Allscripts Healthcare Solutions 14.97 -0.15 -0.99% -17.61%
Merck 171.70 3.85 2.29% 1.63%
Mettler Toledo International 1,171.60 -3.87 -0.33% -18.41%
Novartis 81.22 0.31 0.38% -4.41%
Pfizer 52.75 1.11 2.15% 34.05%
PerkinElmer 145.99 1.43 0.99% -5.84%
Thermo Fisher Scientific 556.04 10.97 2.01% 6.37%
UnitedHealth 515.29 10.05 1.99% 25.17%
United Therapeutics 241.90 4.75 2.00% 29.37%
Waters 342.27 2.61 0.77% -6.33%
Walgreens Boots Alliance 37.78 -0.73 -1.90% -20.45%
West Pharmaceutical Services 315.55 9.49 3.10% -15.33%
Intrexon 1.46 -0.16 -9.88% -75.95%
Dentsply International 35.62 -0.48 -1.33% -44.02%

Indexes Price Day Year
US400 2279 -13.85 -0.60% -15.05%

Charles River Laboratories
Charles River Laboratories International, Inc. is a full service, early-stage contract research company. The Company provides products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions in research and drug development. The Company operates through two segments: Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing). The DSA segment includes services required to take a drug through the early development process including discovery services, which are non-regulated services to assist clients with the identification, screening, and selection of a lead compound for drug development, and regulated and non-regulated (Good Laboratory Practice (GLP) and non-GLP) safety assessment services. The Manufacturing segment includes Microbial Solutions, Biologics Solutions, and Avian Vaccine Services.